Last updated on January 2016

A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects with Treatment-resistant Depression


Brief description of study

A Randomized, Double-blind, Multicenter, Active-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Subjects with Treatment-resistant Depression

Detailed Study Description

This is a study of subjects with TRD to assess the efficacy, safety, and tolerability of intranasal esketamine plus an oral antidepressant compared to an oral antidepressant (active comparator) plus intranasal placebo.

Clinical Study Identifier: TX142276

Contact Investigators or Research Sites near you

Start Over

Karen Schmidt

AMITA Health
Arlington Heights, IL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.